lURIE CANCER CENTER AND Northwestern Medicine
EXPERTS TO PRESENT AT THE 2026 ASCO® Annual Meeting
Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will be attending and presenting leading-edge research in cancer care at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29 – June 2, at McCormick Place in Chicago.
The program features more than 200 sessions complementing the meeting’s theme: The Science and Practice of Translation: Improving Cancer Outcomes Worldwide.
The program features more than 200 sessions complementing the meeting’s theme: The Science and Practice of Translation: Improving Cancer Outcomes Worldwide.
a sample of our presentation schedule
FRIDAY, May 29
|
Time
|
Location
|
Track & Session
|
Presenter
|
Learn More
|
|
3:45 PM
|
S501ABC
|
Symptom Science and Palliative Care
Workshop: Communication in Late-Stage Cancer: Discussing Prognosis and Matching Care to Patients’ Goals Workshop |
SATURDAY, maY 30
|
Care Delivery/Models of Care
Poster Session: Association of routine electronic symptom monitoring with reduced opioid use in patients with head and neck cancers |
|
9:00 AM
|
Hall A - Posters and Exhibits
|
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Poster Session: Post-hoc efficacy and biomarker analysis of elraglusib plus gemcitabine/nabpaclitaxel versus chemotherapy alone in metastatic pancreatic ductal adenocarcinoma |
|
3:00 PM
|
S100A
|
Central Nervous System Tumors
Oral Abstract Session |
Priya U. Kumthekar, MD (Session Chair)
|
SUNDAY, MAY 31
|
9:30 AM
|
S504
|
Pediatric Oncology
Oral Abstract Session: The ASPIRES study: Promoting colorectal cancer surveillance in childhood cancer survivors—A randomized intervention trial from the Childhood Cancer Survivor study (CCSS) |
|
|
12:00 PM
|
S100A
|
A New Era: Clinical Application of Evolving Technologies and Artificial Intelligence in Cancer Care
Education Session: Insights From Developing a Prognostic Model for Breast Cancer |
MONDAY, JUNE 1
|
8:30 AM
|
Hall D1
|
Highlights of the Year II:
Highlights of the Day Session: Highlights of the Year in Breast Cancer: Optimal Management with Antibody Drug Conjugates Across Breast Cancer Stages and Subtypes |
|
1:15 PM
|
S100A
|
Medical Education and Professional Development
Education Session: Practical Considerations for the Use of Artificial Intelligence in Grant Submissions and Publications |
|
1:30 PM
|
Hall A - Posters and Exhibits
|
Breast Cancer—Metastatic
Poster Session: Baseline circulating tumor cells and association with early resistance in patients with metastatic breast cancer undergoing palbociclib therapy |
connect with us on social
Use #ASCO26 to follow and share insights from the meeting on Twitter, tagging:
- Lurie Cancer Center: @LurieCancer
- Northwestern Medicine: @NorthwesternMed
NORTHWESTERN MEDICINE onCOLOGY
|
Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is a global leader in the treatment of a broad range of cancer types due to its dedication to comprehensive clinical oncology research, world-renowned faculty, physicians and oncologists, and its commitment to making breakthroughs in medical, surgical, radiation and interventional oncology.
Lurie Cancer Center is designated by the National Cancer Institute as one of only 57 comprehensive cancer centers in the nation recognized for their scientific leadership, resources and the depth and breadth of their research. In addition, Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN) and our physicians actively participate in writing NCCN patient guidelines for each type cancer. Northwestern Memorial Hospital is proud to be among the top 2% of hospitals in the U.S. for cancer per U.S. News & World Report, 2025 – 2026. |